Ernexa Therapeutics Inc.
13F holders, Q1 2026 (March 31)20holders +6
9new positions
4sold out
1famous investor
$0.20avg. 13F price*
At the end of Q1 2026, 20 institutions reported holding Ernexa Therapeutics Inc. in their 13F filings, up 6 from Q4 2025. 9 opened new positions and 4 sold out. The largest holders were Bleichroeder LP ($398K), Dauntless Investment Group, LLC ($122K) and Corient Private Wealth LP ($87K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ernexa Therapeutics Inc.
- CUSIP
- 114082308
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $559K |
| Exits | 4 | $16K |
All 13F filers, Q4 2025 → Q1 2026: 3,049,125 shares bought and 13,493 shares sold, net +3,035,632 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Bleichroeder LP | 0.07% | New | 2,000,000 | $398K |
| Dauntless Investment Group, LLC | 0.34% | New | 612,443 | $122K |
| Corient Private Wealth LP | 0.00% | Add +0.0% | 438,093 | $87K |
| Geode Capital Management, LLC | 0.00% | Add +935.0% | 244,446 | $49K |
| XTX Topco Ltd | 0.00% | New | 54,338 | $11K |
| Warberg Asset Management LLC | 0.02% | New | 50,000 | $10K |
| Jane Street Group, LLC | 0.00% | New | 41,167 | $8K |
| Citadel Advisors | 0.00% | New | 33,076 | $7K |
| Vanguard Capital Management LLC | 0.00% | — | 26,504 | $5K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 25,447 | $5K |
| UBS Group AG | 0.00% | Add +3438.8% | 21,233 | $4K |
| Goldman Sachs Group Inc. | 0.00% | New | 16,631 | $3K |
| Sippican Capital Advisors | 0.00% | No change | 10,000 | $2K |
| BlackRock, Inc. | 0.00% | No change | 820 | $163 |
| Assetmark, Inc. | 0.00% | No change | 133 | $26 |
| Montag A & Associates Inc. | 0.00% | No change | 8 | $2 |
| BNP Paribas Financial Markets | 0.00% | No change | 10 | $2 |
| SBI Securities Co., Ltd. | 0.00% | New | 6 | $1 |
| Activest Wealth Management | 0.00% | No change | 3 | $1 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ERNEXA THERAPEUTICS INC's weight in each manager's 13F, not the share of Ernexa Therapeutics Inc. the manager owns.